Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 21, 2004
A comparison of health utility measures for the evaluation of multiple sclerosis treatments
J D Fisk, M G Brown, I S Sketris, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 25, 2009
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
L M Metz, D Li, A Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 24, 2013
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes
H Kang, L M Metz, A L Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 28, 2007
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study
R K Zabad, L M Metz, T R Todoruk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 18, 2004
The effect of immunomodulatory treatment on multiple sclerosis fatigue
L M Metz, S B Patten, C J Archibald, et al.
Neurology
|
March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment
C H Polman, S C Reingold, F Barkhof, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of Neurology, Neurosurgery, and Psychiatry
|
December 21, 2004
A comparison of health utility measures for the evaluation of multiple sclerosis treatments
J D Fisk, M G Brown, I S Sketris, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 25, 2009
Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
L M Metz, D Li, A Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 24, 2013
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes
H Kang, L M Metz, A L Traboulsee, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 28, 2007
The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study
R K Zabad, L M Metz, T R Todoruk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 18, 2004
The effect of immunomodulatory treatment on multiple sclerosis fatigue
L M Metz, S B Patten, C J Archibald, et al.
Neurology
|
March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment
C H Polman, S C Reingold, F Barkhof, et al.
Page
of 4